Quantcast

Latest Parkinson's disease Stories

2014-05-27 12:30:25

Nationwide strategic health initiative aims to fill in knowledge gaps and connect patients and caregivers to local resources and one-on-one support NEW YORK, May 27, 2014 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation (MJFF) and AbbVie announced the launch of Partners in Parkinson's, a new strategic health initiative offering comprehensive support to help people with Parkinson's disease (PD) optimize their care at every stage of the disease. "No two cases of Parkinson's disease are...

2014-05-22 08:31:13

--Research Includes Stem Cells, Imaging and Exercise for Cognition-- MIAMI, May 22, 2014 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) announced today that it has funded four new grants in Parkinson's disease (PD) research. The four grants target key scientific questions about how Parkinson's develops and how to optimize treatment. "NPF is propelling the most potentially transformative research forward," said Joyce Oberdorf, NPF's President and CEO. "This...

2014-05-21 08:30:15

Beneufit's first product pdFIT(TM), uses cycling to help Parkinson's disease patients fight symptoms and disease progression SAN FRANCISCO, May 21, 2014 /PRNewswire/ -- Beneufit's pdFIT(TM) system is the first to coach patients through scientifically-validated exercise protocols shown to be associated with a reduction in Parkinson's disease symptoms and delayed disease progression. The system uses mobile devices and wireless sensors to track compliance with exercise protocols and map...

2014-05-16 23:07:47

Transparency Market Research published a new report "Deep Brain Stimulation Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse full report: http://www.transparencymarketresearch.com/deep-brain-stimulator-market.html. Albany, New York (PRWEB) May 16, 2014 A rise in ageing population has been found to be the major causative factor for development of Parkinson’s disease. Parkinson’s disease is the...

2014-05-07 09:50:08

Follow-up study published in the Journal of Parkinson's Disease supports an earlier 'proof of concept' trial A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy. These data provide strong encouragement for the further study of this drug in patients with PD, report researchers in the Journal of Parkinson's Disease....

2014-04-30 23:10:24

Vick is one of less than 100 clinicians across the state, and one of 1,600 worldwide, to earn this certification, according to LSVT Global. Franklin, Va. (PRWEB) April 30, 2014 If you ask Tracey Vick, she’ll tell you she decided to pursue a career in physical therapy after helping her grandfather to his clinical appointments following his stroke. Today, Tidewater Physical Therapy is pleased to announce that Vick, a Physical Therapy Assistant who works with patients in the Franklin, Va....

2014-04-30 08:33:57

Positive Clinician-Reported Patient Assessments Consistent with Earlier Findings Reported with ADS-5102 EMERYVILLE, Calif., April 30, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a specialty pharmaceutical company, today presented data on the safety and efficacy of ADS-5102 for the treatment of levodopa-induced dyskinesia (LID), a serious movement disorder associated with Parkinson's disease treatment. The data, from Adamas' Phase 2/3 EASED study, included...

2014-04-29 08:36:49

GULF SHORES, Ala., April 29, 2014 /PRNewswire/ -- If successful, Neuralgene's (http://www.neuralgene.com) PRCN-323 treatment could significantly change the prognosis for everyone with the rare genetic disorder known as adrenoleukodystrophy, or ALD. The biotech company has recently celebrated a series of early successes in the treatment of other neurological conditions like ALS (Lou Gehrig's disease). Founder and CEO Jason Williams, M.D., believes his team is on the path toward a cure...

2014-04-28 16:27:09

PHILADELPHIA, April 28, 2014 /PRNewswire-USNewswire/ -- A review by the American Academy of Neurology of available scientific research on the use of medical marijuana in brain diseases finds certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but do not appear to be helpful in treating drug-induced (levodopa) movements in Parkinson's disease. Not enough evidence was found to show if medical marijuana is helpful in treating motor problems in...

2014-04-28 12:27:49

NEW YORK, April 28, 2014 /PRNewswire-USNewswire/ -- Founder Michael J. Fox; CEO Todd Sherer, PhD; and Co-Founder and Executive Vice Chairman Deborah W. Brooks of The Michael J. Fox Foundation for Parkinson's Research (MJFF) are featured on the cover of the inaugural issue of Clinical Researcher, the journal of the Association of Clinical Research Professionals. http://photos.prnewswire.com/prnvar/20140425/79262 The April 2014 cover story, authored by Sherer and other MJFF staff, is...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'